Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 5,772 | 4,101 | 6,778 | 5,938 | 3,573 |
| Operating Income | -5,772 | -4,101 | -6,778 | -5,938 | -3,573 |
| Other Income | 64 | 52 | 82 | 61 | 4 |
| Pre-tax Income | -5,708 | -4,049 | -6,696 | -5,877 | -3,569 |
| Net Income Continuous | -5,708 | -4,049 | -6,696 | -5,877 | -3,569 |
| Net Income | $-5,708 | $-4,049 | $-6,696 | $-5,877 | $-3,569 |
| EPS Basic Total Ops | -0.38 | -0.27 | -0.49 | -0.42 | -0.28 |
| EPS Basic Continuous Ops | -0.38 | -0.28 | -0.49 | -0.42 | -0.28 |
| EPS Diluted Total Ops | -0.38 | -0.27 | -0.49 | -0.42 | -0.28 |
| EPS Diluted Continuous Ops | -0.38 | -0.28 | -0.49 | -0.42 | -0.28 |
| EPS Diluted Before Non-Recurring Items | -0.38 | -0.27 | -0.48 | -0.42 | N/A |
| EBITDA(a) | $-5,772 | $-4,101 | $-6,778 | $-5,938 | $-3,573 |